Cagrilintide 5mg + Semaglutide 5mg 10mg / vial Weight Management Thiab Metabolic Health

Cagrilintide 5mg + Semaglutide 5mg ua ke lyophilized hmoov 10mg / lub raj mis - Cov Ntsiab Lus Qhia

Kev tshawb fawb-qib dual-lub hom phiaj sib koom ua ke peptide|Ua nyob rau hauv Suav teb, ntev - ua AMYR / GLP-1R dual agonist ua ke 10mg / vial

Cov khoom xyaw sib xyaw: Cagrilintide 5mg (ntev-acting amylin analog) + Semaglutide 5mg (ntev-acting GLP-1 analog)

Kev sib xyaw ua ke: 1: 1 mass ratio

Purity: Lub purity ntawm txhua yam yog ntau dua los yog sib npaug rau 99.0% (RP-HPLC nrhiav).

Tag nrho cov ntsiab lus peptide: Ntau dua lossis sib npaug li 95.0% (amino acid tsom xam)

Qhov tshwm sim: Dawb los yog tawm -dawb lyophilized hmoov

Cia: Khaws khov ntawm -20℃deb ntawm lub teeb. Tom qab thawing, refrigerate ntawm 2-8 degrees. Tsis txhob rov qab khov-thaw cycles.

Core zoo thiab muaj nuj nqi

Cov khoom no yog qhov tseeb 1: 1 huab hwm coj piv lyophilized hmoov sib txuasCov tshuaj amylintide receptor (AMYR) agonist Cagrilintidethiabglucagon-zoo li peptide-1 receptor (GLP-1R) agonist Semaglutide, sawv cev rau qib siab tshaj plaws ntawm cov tswv yim hauv kev tshawb fawb tam sim no ntawm kev sib xyaw ua ke rau cov kab mob metabolic. Los ntawmob, ntxiv, thiab sib koom ua ke ntawm kev ua haujlwm -ib txhij lub hom phiaj kev noj qab haus huv hauv nruab nrab thiab kev siv hluav taws xob, ncua kev ua pa hauv plab, thiab txhim kho insulin rhiab heev- nws tau ua kom pom qhov kev poob phaus thiab kev txhim kho metabolic tshaj li kev kho mob monotherapy.Hauv kev tshawb fawb preclinical ntawm kev rog, hom 2 mob ntshav qab zib, thiab cuam tshuam txog cov teeb meem metabolic. Nws yogib lub cuab yeej tshawb fawb tseem ceebkom ua tiav lub hom phiaj ntawm "synergistic efficiency thiab txo cov kev mob tshwm sim."

✅ Synergistic mechanism:

Qhov "ob-circuit" inhibition ntawm nruab nrab qab los noj mov:

Semaglutide (GLP-1R txoj kev): Ua rauarcuate nucleus POMC neurons thiab paraventricular nucleus ntawm hypothalamusua kom ntev -sijhawm satiety signals thiab txo kev tshaib kev nqhis.

Cagrilintide (amylinin txoj kev): Ua rau lub hlwb thaj tsam xws liparabrachial nucleus thiab amygdala, tshwj xeeb tshaj yog tswjxeev siab thiab aversion-cov chaw cuam tshuam, ntxiv dag zog rau kev noj zaub mov inhibition, thiab tseem tuaj yeem tswj hwm tus nqi hedonic ntawm cov zaub mov.

Ntau -lub hom phiaj optimization ntawm peripheral metabolism:

Synergistic ncua ntawm lub plab khoob: Ob qho tib si ncua kev ua pa hauv plab, thiab lawv cov txiaj ntsig ntxiv ua kom ntev satiety thiab txo qis cov ntshav qabzib hloov pauv hauv postprandial.

Synergistic kev cai ntawm kev siv hluav taws xob: Cagrilintide tuaj yeem nce kev siv hluav taws xob me ntsis, ntxiv rau kev tswj hwm qhov hnyav ntawm semaglutide.

Txhim kho qhov rhiab heev ntawm insulin: Los ntawm kev poob phaus thiab kev ua haujlwm ncaj qha, nws ua ke txhim kho cov lus teb ntawm peripheral cov ntaub so ntswg rau insulin.

Clinical zoo:

Muaj zog poob qhov hnyav: Preclinical and early clinical data show a weight loss effect of 1+1>2.

Superior metabolic txhim kho: Thaum txo qhov hnyav, nws tseem muab kev txhim kho ntau dua hauv cov kab mob plawv metabolic xws li ntshav qab zib, ntshav lipids, thiab ntshav siab.

Muaj peev xwm tolerability optimization: Los ntawm kev siv tshuab ua kom zoo dua qub, nws tuaj yeem siv tau tsawg dua ntawm kev kho mob monotherapy, yog li txo cov kev mob plab hnyuv uas yuav tshwm sim los ntawm kev siv tshuaj ntau ntawm monotherapy.

✅Qualityqhov zoo ntawm Suav manufacturers:

High purity ntawm cov khoom guaranteed:

Cagrilintide: Kev sivsite- qhia txog kev hloov kho cov roj fatty acid, nws cov purity yog ntau dua los yog sib npaug rau 99.0%, kom ntseeg tau ntev -AMYR agonist kev ua haujlwm.

Semaglutide: Kev sivoptimized fermentation thiab purification txheej txheem, nws ua tiav qhov purity ntawm Ntau dua lossis sib npaug rau 99.0% thiab ua pov thawj zoo ib yamfatty acid side chain modifications thiab spatial structures with the original drug.

Cov txheej txheem meej meej thiab co- khov- txheej txheem ziab:

High-precision micro- qhov hnyav thiab kev sib xyaw tshuabyog siv los xyuas kom meej qhov tseeb ntawm 1: 1 huab hwm coj piv, nrog batch - rau -batch variation ntawm<±2%.

Los ntawm kev ua haujlwmadvanced co- khov- ziab formulations thiab txheej txheem , stability, compatibility, thiab uniformityntawm ob lub peptides thaum lub sij hawm khov- ziab thiab rov kho dua tshiab tau lees paub, tiv thaiv kev sib sau los yog kev puas tsuaj los ntawm kev sib cuam tshuam.

Kev tswj hwm nruj nruj thoob plaws hauv tag nrho cov txheej txheem:

Kev txheeb xyuas: Ob lub ntsiab lus tau lees paub los ntawm HPLC peptide chromatogram thiab huab hwm coj spectrometry, ntsig txog.

Cov ntsiab lus: Cov ntsiab lus ntawm Cagrilintide thiab Semaglutide tau txiav txim siab los ntawm HPLC txoj kev tshwj xeeb, thiab txhua tus tau tswj hwm los ntawm 90.0% -110.0% ntawm cov ntawv sau npe.

Cov khoom muaj feem xyuam: tswj ib qho impurities Tsawg dua lossis sib npaug li 0.5%, tag nrho impurities Tsawg dua lossis sib npaug li 2.0%.

Kev ua validation: Cell- raws li cAMP kev sim ua haujlwm tau ua kom siv taukev ua haujlwm agonistic tawm tsam AMYR thiab GLP-1R(EC50 qhov tseem ceeb raws li cov qauv).

Kev nyab xeeb ntsuas: Cov kab mob endotoxin<10 EU/mg, sterility test meets the requirements.

Ua kom tiav kev sib piv: Muab cov ntaub ntawv sib piv cov yam ntxwv zoo (CQA).ntawm ob lub ntsiab lus nrog lawv cov khoom qub / cov khoom siv, suav nrog cov qauv thawj, cov qauv siab dua, purity profile, kev ua haujlwm, thiab lwm yam, los ua kom pom lawv qhov sib xws.

✅ khoomNta:

Daim ntawv qhia meej: Optimized 1: 1 tsau- koob tshuaj ua ke muab cov cuab yeej txheem rau kev tshawb fawb txog kev sib koom ua ke.

Synergistic thiab muaj txiaj ntsig: Cov ntaub ntawv preclinical tau lees paub tias kev siv tshuaj sib xyaw ua ke muaj txiaj ntsig zoo dua qhov hnyav dua li cov khoom siv ib leeg siv.

Complementary mechanisms: npog cov kab hluav taws xob sib txawv thiab cov phiaj xwm kab ke ntsig txog kev tswj hwm kev noj zaub mov thiab lub zog sib npaug.

Tus qauv kub rau kev tshawb fawb: muab kev ntseeg siab, siab - cov ntaub ntawv zoo rau kev ntsuas "Cagri+Sema" ua ke lub tswv yim.

Daim ntawv qhia kev siv thiab cia

1. Kev kho dua tshiab thiab kev npaj:

Cov kuab tshuaj tshwj xeeb:

Cov nrog tshwj xeeb reconstitution diluent(feem ntau yog dej rau kev txhaj tshuaj uas muaj cov buffers tshwj xeeb thiab stabilizers, pH kwv yees li 8.0-8.5) yuav tsum tau siv los xyuas kom meej qhov ruaj khov ntawm ob qho tib si peptides ib txhij.

Kev siv cov dej qab ntsev zoo tib yam, cov dej tsis muaj menyuam rau kev txhaj tshuaj, lossis cov kev daws teeb meem nrog pH tsis sib haum yog txwv nruj..

Tus txheej txheem npaj:

Maj mam txhaj 1.0 mL ntawm qhov tshwj xeeb diluent raws phab ntsa sab hauv ntawm lub vial.

Maj mam tiglub vial horizontally nyob rau hauv xib-teg ntawm koj txhais tes tsawg kawg yog 2-3 feeb kom txog thaum lub ncuav mog qab zib khov-qhuav yog yaj tag, tsim ib qho ntshiab, tsis muaj xim isotonic tov.Tsis txhob muaj kev tshee, tshee, lossis vortexing.

Mixed stock daws ntawmCagrilintide 5 mg / mL + Semaglutide 5 mg / mLtau txais (tag nrho cov concentration 10 mg / mL).

Yog tias yuav tsum tau txhaj tshuaj, nws tuaj yeem ntxiv diluted nrogib qho tshwj xeeb diluent lossis physiological saline uas muaj 0.1% tib neeg cov ntshav albuminthiab ces maj mam sib tov.

Cov ntsiab lus tseem ceeb kom nco ntsoov:

Reconstitution raug pom zoo kom ua nyob rau hauv chav tsev kub.

Cov tshuaj reconstituted yuav tsum tau sivhauv 1 teevtiv thaiv degradation los yog aggregation.

Ua ntej muab cov tshuaj, nco ntsoov xyuas qhov muag pom kev. Nws yuav tsum yogntshiab, tsis muaj xim, thiab tsis pom cov khoom.

Cov khoom no yogib qho ruaj khov - koob tshuaj; tsis txhobsim cais ob yam khoom los yog kho lawv qhov sib piv.

2. Cia tej yam kev mob:

Unreconstituted lyophilized hmoov:

Khaws khov ntawm -20℃± 5 degree, tiv thaiv los ntawm lub teeb nyob rau hauv thawj ntim.

Nyob rau hauv cov xwm txheej no, lub sij hawm siv tau yog teem caij tentativelyua 24ay.

Rau ntev - khaws cia ntev, nws raug nquahu kom khaws ciantawm -80 degree.

Rov qab khov thiab thawing yog txwv tsis pub.

Reconstituted daws:

Yog tias tsis siv tam sim ntawd, nws tuaj yeem ua taumuab tso rau hauv tub yees ntawm 2-8℃tsis pub ntau tshaj 24 teev.

Nws tsis pom zoo kom khov cov tshuaj kho dua tshiab.

Kev thauj mus los:

Nws yuav tsumraug thauj siv cov dej khov qhuav (-78 degree) thoob plaws tag nrho cov txheej txheem.

Lub ntsuas kub yuav tsum tau muab tso rau hauv lub ntim.

3. Kev tshawb fawb thiab kev npaj ua ntawv thov:

Preclinical tsiaj qauv:

Core qauv:

Khoom noj khoom haus-induced rog (DIO) nas/rats: ntsuam xyuas qhov hnyav poob, kev hloov hauv lub cev muaj pes tsawg leeg, kev noj zaub mov, thiab kev siv zog.

Zucker Diabetic Obese (ZDF) naslos yogob/ob, db/db nas: txhawm rau ntsuas qhov sib xyaw ua ke ntawm kev txhim kho cov ntshav qabzib, insulin rhiab heev, thiab ua haujlwm pancreatic.

Ib qho - rog, siab - noj fructose - ua rau tus qauv uas tsis yog-coholic steatohepatitis (NASH): Kev soj ntsuam kev sib xyaw ua ke tiv thaiv kab mob siab steatosis, o, thiab fibrosis.

Dosage regimen:

Txoj kev pom zoo: txhaj tshuaj subcutaneous.

Dosage reference(raws li tag nrho cov peptide loj, yuav tsum tau ua ntej kev sim optimization):

Tsawg- pawg koob tshuaj: 0.1 - 0.3 mg/kg

Cov koob tshuaj nruab nrab: 0.3 - 1.0 mg/kg

Siab - pawg koob tshuaj: 1.0 - 3.0 mg/kg

Dosing zaus: Txij li ob qho tib si ntev - ua cov qauv tsim, lawv tuaj yeem tsim los tswj hwmib zaug ib lub lim tiam.

Kev kho mob thiab kev saib xyuas:

luv- lub sij hawm ua tau zoo: 4-8 lub lis piam.

Ntev - lub sij hawm ua tau zoo thiab cov txheej txheem: 12-24 lub lis piam.

Kev soj ntsuam cov ntsuas: qhov hnyav, kev noj zaub mov, lub cev muaj pes tsawg leeg (DXA lossis MRI), ntshav qabzib ceev, ntsuas qhov ncauj qhov ncauj (OGTT), ntsuas ntshav siab (ITT), ntshav lipids, lub siab enzymes, cov ntsiab lus intrahepatic lipid, histopathology, thiab lub zog metabolism (indirect calorimetry).

Mechanism ntawm kev kawm ua:

Central mechanisms: Siv cov tswv yim xws li microinjection rau hauv cov cheeb tsam hauv hlwb, c-Fos immunohistochemistry, chemogenetics/optogenetics, thiab lwm yam, peb tau soj ntsuam cov qauv ua kom muaj zog thiab qhov chaw sib koom ua ke ntawm ob qho tib si ntawm kev pub noj sib txawv - ntsig txog neural circuits.

Peripheral mechanisms: Cov tshuaj hyperinsulin-orthoglucose clamp kuaj tau ua los ntsuas lub cev thiab cov ntaub so ntswg- cov tshuaj insulin tshwj xeeb; Cov teebmeem ntawm plab hnyuv thiab plab hnyuv cov tshuaj hormone secretion tau tshawb xyuas.

Kev ntsuas kev nyab xeeb: Saib xyuas cov kev mob tshwm sim hauv plab hnyuv (xws li qhov hnyav poob vim kev noj zaub mov kom tsawg), lub plawv dhia, ntshav siab, thiab lwm yam.

4. Cov tswv yim tsim kev sim:

Tswj pab pawg teeb tsa(tseem ceeb):

Solvent tswj pawg

Cagrilintide monotherapy pab pawg(equimolar koob tshuaj)

Semaglutide monotherapy pab pawg(equimolar koob tshuaj)

Qhov no compound pawg

(Yeem) Lwm pawg tshuaj tswj tau zoo

Dosage tsim: Nws raug nquahu kom ua tiav cov koob tshuaj - teb cov lus teb thiab tshuaj xyuas qhov ntsuas kev sib koom ua ke.

Vim li cas thiaj xaiv Suav - ua Cagrilintide + Semaglutide ua ke?

A tus thawj coj nyob rau hauv compound technology: Peb tau kov yeej cov teeb meem ntawmmeej proportioning, compatibility, thiab co- khov- ziab ntawm ob ntev - ua peptides nrog cov qauv sib txawv thiab kev hloov kho, kom ntseeg tau tias qhov sib xws, ruaj khov, thiab kev ua haujlwmntawm cov khoom sib xyaw.

Zoooriginates los ntawm kev tsim: tswj los ntawm qhov chaw ntawm cov ntaub ntawv raw, coj mus rau hauv - qhov tob tus yam ntxwv ntawm ob lub ntsiab lus, thiab ua tiav kev tshawb fawb zoo ntawm cov khoom sib xyaw kom ntseeg tau tias muaj kev sib koom ua ke ntawm1+1 > 2tuaj yeem kawm ntseeg tau.

Muaj zogmuab saw hlau thiab customization muaj peev xwm: Peb tuaj yeem muab cov khoom zoo siab - cov ntaub ntawv zoo thiab muab cov khoom sib xyaw ua kenrog sib txawv proportions raws li kev tshawb fawb xav tau.

Zoo heevnqi-effectiveness: Muab piv rau kev yuav khoom ob yam sib cais thiab sib xyaw rau koj tus kheej, cov khoom sib xyaw no txuag cov nqi thiab sijhawm, thiab tshem tawmqhov kev faib ua yuam kev, kev pheej hmoo ntawm kev sib raug zoo, thiab kev ua haujlwm tsis raug uas yuav tshwm sim los ntawm tus kheej - sib xyaw. Nws yog thawj qhov kev xaiv rau cov neeg uas nrhiav kev ua haujlwm siab - ua haujlwm tau zoo thiab siab - kev tshawb fawb zoo.

Tshawb nrhiav thiab siv cov lus qhia

Mechanism ntawm synergistic kev kho mob rau cov kab mob metabolic:

Tus ntoo khaub lig-Kev sib txuas lus thiab kev sib koom ua ke ntawm amylin thiab GLP-1 qhia txoj hauv kev hauv cov chaw pub mis xws li hypothalamus thiab lub hlwb.

Cov nyhuv synergistic ntawm kev siv tshuaj sib xyaw ua ke hauv kev txo cov rog rog thiab txhim kho daim siab rog metabolism.

Synergistic txhim kho cov nyhuv thiab cov txheej txheem ntawm cov kab mob plawv metabolic.

Kev kho tshiab thiab kho kom zoo:

Qhov no muab cov txheej txheem siv tshuab thiab kev ua tau zoo rau kev txhim kho ntawm dual- phiaj xwm ib leeg- cov tshuaj molecule xws li AMG 133.

Txhawm rau tshawb xyuas qhov pom zoo npaum li cas, zaus, thiab lub sijhawm kho, muab lub hauv paus rau kev tsim kho raws tu qauv.

Txhawm rau ntsuas nws cov peev xwm kho mob hauv cov neeg tshwj xeeb, xws li cov neeg mob rog rog nrog NASH.

Txhais cov tshuaj thiab biomarkers:

Txhawm rau txheeb xyuas biomarkers uas tuaj yeem kwv yees cov lus teb rau "Cagri + Sema" kev sib xyaw ua ke.

Txhawm rau tshawb nrhiav qhov cuam tshuam ntawm kev kho lub sijhawm ntev - ntawm kev nco txog metabolic thiab kho cov ntaub so ntswg.

Preclinical kev tshawb fawb cov ntaub ntawv siv

Synergistic poob phaus: Hauv DIO qauv, qhov hnyav poob ntawm cov tshuaj sib xyaw ua ke yog qhov zoo dua li cov txiaj ntsig ntawm txhua qhov kev siv ib leeg, qhia meej.synergistic nyhuv.

Cov txiaj ntsig zoo metabolic: Cov pab pawg kho mob ua ke feem ntau pomzoo dua thiab ntau duaKev txhim kho hauv kev txhim kho cov tshuaj insulin, txo cov rog hauv siab, thiab tswj cov ntshav lipids.

Tolerability: Cov kev tshawb fawb preclinical qhia tias, thaum ua tiav qhov sib npaug lossis zoo dua, kev kho ua ke yuav muajzoo dua tolerability vim qhov tsawg dua npaum li cas ntawm txhua feem.

Cov ntsiab lus

ib qho piv txwvntawm "synergistic therapy" lub tswv yim hauv kev txhim kho cov kab mob metabolic. Cov khoom no ua ke ob lub chaw kho mob tau lees paub, siab - potency molecules nrog cov txheej txheem sib txawv ntawm kev ua, muab cov cuab yeej tshawb fawb uas tsis tuaj yeem hloov pauv rau kev tshawb nrhiavmuaj zog dua, muaj kev nyab xeeb dua, thiab ntau txoj kev kho mob rau cov kab mob metabolic. Xaiv cov khoom no txhais tau tias xaivkev ua tau zoo, txhim khu kev qha, thiab txiav - txoj kev tshawb fawb ntug, pab koj ua tiav txoj haujlwm tseem ceeb hauv kev sib tw heev ntawm kev tshawb fawb metabolic.

Xav taudab tsi, thov hu raupeb

Cim npe nrov: cagrilintide 5mg + semaglutide 5mg 10mg / vial hnyav tswj thiab metabolic noj qab haus huv, Tuam Tshoj cagrilintide 5mg + semaglutide 5mg 10mg / vial luj tswj thiab metabolic noj qab haus huv manufacturers, lwm tus neeg, Hoobkas